Dr. Sepuri Krishna Mohan (Endocrinology) needs a second opinion on this medical case.
Dear my friends and fellow Colleagues,
In patients at increased cardiovascular risk receiving metformin-based background therapy, specific GLP-1 RAs and SGLT-2 inhibitors have a favorable effect on certain cardiovascular outcomes.
Annals of Internal Medicine.
30th June, 2020.
Regards and thanks,
Dr Sepuri Krishna Mohan.